Elite Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $0.014; its P/E ratio is 9.12; Elite Pharmaceuticals is scheduled to report earnings on June 12, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 15.54M	$ 14.16M	$ 9.00M	$ 8.65M	$ 9.25M
Gross Profit	$ 7.04M	$ 6.45M	$ 4.75M	$ 3.85M	$ 4.92M
EBIT	$ 77.18K	$ -2.60M	$ 1.42M	$ 155.48K	$ 3.33M
EBITDA	$ 420.79K	$ -2.27M	$ 1.75M	$ 485.40K	$ 3.65M
Net Income Common Stockholders	$ 706.35K	$ 14.97M	$ 1.14M	$ -1.23M	$ 2.97M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 5.82M	$ 8.65M	$ 9.08M	$ 7.83M	$ 17.91M
Total Assets	$ 74.70M	$ 70.72M	$ 46.50M	$ 40.90M	$ 52.72M
Total Debt	$ 7.89M	$ 7.65M	$ 7.84M	$ 3.89M	$ 15.98M
Net Debt	$ 2.07M	$ -1.00M	$ -1.24M	$ -3.94M	$ -1.93M
Total Liabilities	$ 28.28M	$ 25.62M	$ 16.38M	$ 11.94M	$ 22.54M
Stockholders Equity	$ 46.41M	$ 45.09M	$ 30.12M	$ 28.96M	$ 30.17M
Cash Flow	-
Free Cash Flow	$ -2.80M	$ -235.94K	$ -2.71M	$ 2.43M	$ -568.59K
Operating Cash Flow	$ -2.40M	$ -235.94K	$ -2.71M	$ 2.97M	$ -567.88K
Investing Cash Flow	$ -406.01K	-	-	$ -536.21K	$ -711.00
Financing Cash Flow	$ -30.65K	$ -179.50K	$ 3.96M	$ -12.50M	$ -77.37K

Currency in USD

Elite Pharmaceuticals Earnings and Revenue History

Income Statement >

Elite Pharmaceuticals Debt to Assets

Balance Sheet >

Elite Pharmaceuticals Cash Flow

Cash Flow >

Elite Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing